LANSING, Mich.--(BUSINESS WIRE)--Michigan Biotechnology Institute (MBI) and Michigan State University (MSU) have entered into a new collaborative arrangement, under which promising bio-based technologies will be accelerated from the laboratory to commercial deployment. The agreement combines MSU’s research expertise with MBI’s derisking process and state-of-the-art bioprocessing facilities to quickly and efficiently demonstrate the market-readiness of new technologies. Intellectual property arising from the collaboration will be bundled, providing industrial partners with both a more valuable technology package and a streamlined process for accessing the technology.
